Effects of Hydrolysates from Silkworms Fed Cudrania tricuspidata Leaves on Improvement of Memory in Rats with Impaired Memory Induced by Scopolamine
Source abstract
Abstract
This study investigated the memory-improving effects and mechanisms of action of hydrolysate from silkworm fed Cudrania tricuspidata leaves (HSCT) in rats with scopolamine-induced memory impairment. Thirty-two rats were categorized into 4 groups and the experiment was conducted for 6 weeks. The experimental diet groups are as follows: control, control diet; scopolamine, control diet + scopolamine (0.7 mg/kg); HSCT, HSCT diet + scopolamine (0.7 mg/kg); and donepezil, control diet + scopolamine (0.7 mg/kg) + donepezil (1.0 mg/kg). Except for the control group, the experimental groups received scopolamine 0.7 mg/kg intraperitoneally to induce decline in memory. Animal behavioral tests such as the Barnes maze, novel object recognition test, and Y-maze were performed to investigate the effects of HSCT on memory improvement. In addition, brain acetylcholine (ACh) concentration and acetylcholinesterase (AChE) activity were assessed to investigate the mechanism of memory improvement. Results of the animal behavior test suggested that the rats administered HSCT displayed improved memory behavior compared to those administered scopolamine (p < 0.05). The concentration of Ach was increased in the HSCT group compared to the scopolamine group (p < 0.05), and the activity of AChE was significantly reduced (p < 0.05). These results suggest that HSCT effectively improves memory by reducing AChE activity and increasing ACh content in the brains of rats with scopolamine-induced memory impairment. As a natural compound, HSCT has the potential to be used as a material to improve memory.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Medicinal Plants and Neuroprotection · Cholinesterase and Neurodegenerative Diseases · Protein Hydrolysis and Bioactive Peptides
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Food Science and Biotechnology, Sahmyook University, Seoul 01795, Republic of Korea
Department of Integrative Biotechnology, Sahmyook University, Seoul 01795, Republic of Korea
RMI Center, Nutricare Co., Ltd., Seoul 25250, Republic of Korea
Funding
Rural Development Administration
References (52)
Show source-provided references
1. Knowledge, attitude, and performance of nurses in a tertiary hospital toward older adults10.17079/jkgn.2020.22.2.165 ↗
2. Population aging and generational conflict: Intergenerational equity over resource allocation10.16881/jss.2022.04.33.2.149 ↗
3. Status of health and nutritional intake of the elderly in long-term care facilities: Focus on Gwangju Metropolitan City10.4163/jnh.2020.53.1.27 ↗
4. A study on risk factors for the prevalence of dementia: Geographically weighted regression
5. Dementia prevention, intervention, and care10.1016/S0140-6736(17)31363-6 ↗
6. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission10.1016/S0140-6736(20)30367-6 ↗
7. Resistance to Alzheimer disease neuropathologic changes and apparent cognitive resilience in the Nun and Honolulu-Asia Aging Studies10.1093/jnen/nlx030 ↗
8. The prevalence and incidence of dementia due to Alzheimer’s disease: A systematic review and meta-analysis10.1017/cjn.2016.36 ↗
9. Muscarinic and nicotinic acetylcholine receptor agonists: Current scenario in Alzheimer’s disease therapy10.1111/jphp.12919 ↗
10. Acetylcholine and the complex interdependence of memory and attention10.1016/j.cobeha.2020.01.013 ↗
11. The role of acetylcholine in learning and memory10.1016/j.conb.2006.09.002 ↗
12. Rubus Coreanus Miquel Improves on Impairment of Memory in Senescence-Accelerated Mouse (SAM)10.3746/jkfn.2012.41.9.1253 ↗
13. The effects of vitamin D on learning and memory of hypothyroid juvenile rats and brain tissue acetylcholinesterase activity and oxidative stress indicators10.1007/s00210-021-02195-y ↗
14. Past and Future of Drug Treatments for Alzheimer’s Disease10.4306/jknpa.2018.57.1.30 ↗
15. In-vivo measurement of activated microglia in dementia10.1016/S0140-6736(01)05625-2 ↗
16. A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease10.1212/WNL.0b013e318228bf11 ↗
17. Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe10.1212/WNL.0b013e3181d6476a ↗
18. Aspirin in Alzheimer’s disease (AD2000): A randomised open-label trial10.1016/S1474-4422(07)70293-4 ↗
19. Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer’s disease
20. The use of silkworm pupae (Bombyx mori) meal as an alternative protein source for poultry10.1080/00439339.2023.2163955 ↗
21. Identification of peptides from edible silkworm pupae (Bombyx mori) protein hydrolysates with antioxidant activity10.1016/j.jff.2022.105052 ↗
22. Effects of Silkworm Extract Powder on Plasma Lipids and Glucose in Rats
23. The mass production technology and pharmaceutical effect of silkworm cordyceps (Peacilomyces tenuipes)
24. Effects of compound Caoshi silkworm granules on stable COPD patients and their relationship with gut microbiota. A randomized controlled trial10.1097/MD.0000000000020511 ↗
25. Protein hydrolysate of silkworm pupa prevents memory impairment induced by oxidative stress in scopolamine-induced mice via modulating the cholinergic nervous system and antioxidant defense system10.3746/pnf.2020.25.4.389 ↗
26. Zhou, Y., Zhou, S., Duan, H., Wang, H., and Yan, W. (2022). Silkworm pupae: A functional food with health benefits for humans. Foods, 11.10.3390/foods11111594 ↗
27. A study on quality characteristics of Kimchi with added mulberry leaves extracts
28. Anti-diabetic effect of the mixture of mulberry leaf and green tea powder in rats with streptozotocin-induced diabetes10.11002/kjfp.2014.21.4.549 ↗
29. Yamamoto, K., Yamada, N., Endo, S., Kurogi, K., Sakakibara, Y., and Suiko, M. (2022). Novel silkworm (Bombyx mori) sulfotransferase SWSULT ST3 is involved in metabolism of polyphenols from mulberry leaves. PLoS ONE, 17.10.1371/journal.pone.0270804 ↗
30. Inhibition of adipogenesis in 3T3-L1 adipocytes with water and ethanol extracts of Cudrania tricuspidata Leaves10.11002/kjfp.2011.18.2.244 ↗
31. Physiological activities of extracts from different parts of Cudrania tricuspidata10.3746/jkfn.2011.40.7.942 ↗
32. Evaluation of Cudrania tricuspidata leaves on antioxidant activities and physicochemical properties of pork patties10.5851/kosfa.2018.e22 ↗
33. Quantitative analysis of chemical components of hydrolysate from silkworm fed with Cudrania tricuspidata Leaves10.15616/BSL.2022.28.4.322 ↗
34. Azm, N.A.E., Fleita, D., Rifaat, D., Mpingirika, E.Z., Amleh, A., and El-Sayed, M.M.H. (2019). Production of bioactive compounds from the sulfated polysaccharides extracts of ulva lactuca: Post-extraction enzymatic hydrolysis followed by ion-exchange chromatographic fractionation. Molecules, 24.10.3390/molecules24112132 ↗
35. Effect of degree of hydrolysis on the antioxidant activity of loach (Misgurnus anguillicaudatus) protein hydrolysates10.1016/j.ifset.2008.08.007 ↗
36. Anti-oxidative and neuroprotective activities of pig skin gelatin hydrolysates10.5851/kosfa.2013.33.2.258 ↗
37. In vivo mapping od cerebral acetylcholinesterase activity in aging and Alzheimer’s disease10.1212/WNL.52.4.691 ↗
38. Donepezil dose dependently inhibits acetylcholinesterase activity in various areas and in the presynaptic cholinergic and the postsynaptic cholinoceptive enzyme-positive structures in the human and rat brain10.1016/S0306-4522(00)00335-3 ↗
39. On neurodegenerative diseases, models, and treatment strategies: Lessons learned and lessons forgotten a generation following the cholinergic hypothesis10.1006/exnr.2000.7397 ↗
40. Scopolamine model of dementia: Electroencephalogram findings and cognitive performance10.1046/j.1365-2362.1998.00393.x ↗
41. Protective mechanism of cirsium japonicum var. maackii against scopolamine-induced cognitive impairment
42. Developments of a water-maze procedure for studying spatial learning in the rat10.1016/0165-0270(84)90007-4 ↗
43. Deletion of AhR attenuates fear memory leaving other types of memory intact10.1016/j.bbr.2023.114505 ↗
44. Assessment of spatial learning and memory in the Barnes maze task in rodents—Methodological consideration
45. Dopaminergic agonist pramipexole improves memory and increases IL-10 production in LPS-challenged rats
46. Investigating the effect of Crataegus pinnatifida, a functional food, on cognition and memory deficit10.11002/kjfp.2019.26.2.238 ↗
47. Effectiveness and tolerability of high-dose (23 mg/d) versus standard dose (10 mg/d) donepezil in moderate to severe Alzheimer’s disease: A 24-week, randomized, double-blind study10.1016/j.clinthera.2010.06.019 ↗
48. Pharmacotherapy for dementia10.5124/jkma.2018.61.12.758 ↗
49. Cognition improving effect of the compositions prepared with extracts of Wongam, Sorghum bicolor (L.) Moench and pupae of Bombyx mori L.10.11002/kjfp.2021.28.7.989 ↗
50. Prieur, E.A.K., and Jadavii, N.M. (2019). Assessing spatial working memory using the spontaneous alternation Y-maze test in aged male mice. Bio Protoc., 9.10.21769/BioProtoc.3162 ↗
51. Caffeine prevents disruption of memory consolidation in the inhibitory avoidance and novel object recognition tasks by scopolamine in adult mice10.1016/j.bbr.2010.05.034 ↗
52. A meta-analysis of randomised controlled trials of physical activity in people with Alzheimer’s disease and mild cognitive impairment with a comparison to donepezil10.1002/gps.5581 ↗